149 related articles for article (PubMed ID: 32381956)
1. [Ⅲ.The Current Status and Future Perspective of Chemotherapy, Targeted Therapy and Immunotherapy for Cervical Cancer].
Yabuno A; Hasegawa K
Gan To Kagaku Ryoho; 2020 Feb; 47(2):242-246. PubMed ID: 32381956
[No Abstract] [Full Text] [Related]
2. Immunotherapy and targeted therapy for cervical cancer: an update.
Menderes G; Black J; Schwab CL; Santin AD
Expert Rev Anticancer Ther; 2016; 16(1):83-98. PubMed ID: 26568261
[TBL] [Abstract][Full Text] [Related]
3. Treatment of metastatic cervical cancer: future directions involving targeted agents.
Diaz-Padilla I; Monk BJ; Mackay HJ; Oaknin A
Crit Rev Oncol Hematol; 2013 Mar; 85(3):303-14. PubMed ID: 22883215
[TBL] [Abstract][Full Text] [Related]
4. Current and potential treatments for cervical cancer.
Yee GP; de Souza P; Khachigian LM
Curr Cancer Drug Targets; 2013 Feb; 13(2):205-20. PubMed ID: 23259831
[TBL] [Abstract][Full Text] [Related]
5. Beyond Chemotherapy: An Overview and Review of Targeted Therapy in Cervical Cancer.
Crafton SM; Salani R
Clin Ther; 2016 Mar; 38(3):449-58. PubMed ID: 26926322
[TBL] [Abstract][Full Text] [Related]
6. [Current Status and Perspective of Chemoradiotherapy for Uterine Cervical Cancer].
Toita T; Ariga T; Kasuya G; Hashimoto S; Maemoto H; Heianna J; Kakinohana Y; Murayama S
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1156-61. PubMed ID: 26489545
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapy in cervical cancer: 30 years in review.
Liontos M; Kyriazoglou A; Dimitriadis I; Dimopoulos MA; Bamias A
Crit Rev Oncol Hematol; 2019 May; 137():9-17. PubMed ID: 31014518
[TBL] [Abstract][Full Text] [Related]
8. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy.
van Meir H; Kenter GG; Burggraaf J; Kroep JR; Welters MJ; Melief CJ; van der Burg SH; van Poelgeest MI
Anticancer Agents Med Chem; 2014 Feb; 14(2):190-203. PubMed ID: 24237223
[TBL] [Abstract][Full Text] [Related]
9. [Ⅲ. Recent Trends in Chemotherapy, Targeted Therapy and Immunotherapy for Cervical Cancer and Promising New Treatments].
Miwa M; Hasegawa K
Gan To Kagaku Ryoho; 2022 Feb; 49(2):155-160. PubMed ID: 35249050
[No Abstract] [Full Text] [Related]
10. Immunotherapy: an evolving paradigm in the treatment of advanced cervical cancer.
Eskander RN; Tewari KS
Clin Ther; 2015 Jan; 37(1):20-38. PubMed ID: 25592089
[TBL] [Abstract][Full Text] [Related]
11. Highlights from the Society of Gynecologic Oncology's 50th Annual Meeting on Women's Cancer.
English DP; Huang M
Gynecol Oncol; 2019 Jun; 153(3):467-470. PubMed ID: 31023555
[No Abstract] [Full Text] [Related]
12. [Ⅰ. Immunotherapy in Cervical Cancer-Current Approaches and Future Horizons].
Iwata T; Matsui T; Matsuda R; Katoh Y; Sugawara M; Nogami Y; Nishio H; Yamagami W
Gan To Kagaku Ryoho; 2024 Feb; 51(2):134-137. PubMed ID: 38449397
[No Abstract] [Full Text] [Related]
13. Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer. Cervical Cancer Immunotherapy Study Group.
Noda K; Teshima K; Tekeuti K; Hasegawa K; Inoue K; Yamashita K; Sawaragi I; Nakajima T; Takashima E; Ikeuchi M
Gynecol Oncol; 1989 Dec; 35(3):367-72. PubMed ID: 2689304
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for gynecologic cancers.
Liao JB
Gynecol Oncol; 2016 Jul; 142(1):3-5. PubMed ID: 27242186
[No Abstract] [Full Text] [Related]
15. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
Valdespino-Gómez VM
Cir Cir; 2005; 73(1):57-69. PubMed ID: 15888272
[TBL] [Abstract][Full Text] [Related]
16. Potential immunotherapy targets in recurrent cervical cancer.
Ring KL; Yemelyanova AV; Soliman PT; Frumovitz MM; Jazaeri AA
Gynecol Oncol; 2017 Jun; 145(3):462-468. PubMed ID: 28233576
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer. Cervical Cancer Immunotherapy Study Group.
Cancer; 1987 Nov; 60(10):2394-402. PubMed ID: 2889522
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy and targeted therapy in the management of cervical cancer.
Kumar L; Harish P; Malik PS; Khurana S
Curr Probl Cancer; 2018; 42(2):120-128. PubMed ID: 29530393
[TBL] [Abstract][Full Text] [Related]
19. Biologics in cervical cancer therapy.
Willmott LJ; Sumner DA; Monk BJ
J Natl Compr Canc Netw; 2010 Dec; 8(12):1417-23. PubMed ID: 21147904
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
Lee SJ; Yang A; Wu TC; Hung CF
J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
